In vitro susceptibility of borrelia spielmanii to antimicrobial agents commonly used for treatment of lyme disease

Kristina Morgenstern, Georg Baljer, Douglas E. Norris, Peter Kraiczy, Christa Hanssen-Hübner, Klaus Peter Hunfeld

Research output: Contribution to journalArticle

Abstract

Ten isolates of the recently delineated genospecies Borrelia spietmanii were tested against antimicrobial agents used to treat Lyme disease and compared to eight isolates of the other three human-pathogenic borrelial genospecies. Despite some small but significant differences in four out of eight antibiotic agents, the susceptibility pattern of B. spielmanii mainly parallels that of the other known human-pathogenic members of the B. burgdorferi sensu lato complex.

Original languageEnglish (US)
Pages (from-to)1281-1284
Number of pages4
JournalAntimicrobial agents and chemotherapy
Volume53
Issue number3
DOIs
StatePublished - Mar 1 2009

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro susceptibility of borrelia spielmanii to antimicrobial agents commonly used for treatment of lyme disease'. Together they form a unique fingerprint.

  • Cite this